cognitive cybersecurity intelligence

News and Analysis

Precision BioSciences (DTIL) Provides Updates on Azer-Cel FDA Meeting

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that it has received final meeting minutes from its recent Type B End of Phase 1 meeting with the U.S. Food and…

Source: www.streetinsider.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market

Biopharma has finally begun catching up with the overall stock market, if the positive returns shown by the top three exchange traded funds (ETFs) since

The debate on English tests for immigrant nurses

As a research scientist who is devoted to ensuring that immigrant nurses have successful U.S. careers, the issue of internationally educated nurses’ (IENs’) cross-culture language

Celebrating internal medicine through our human connections with patients

Students have been sharing with me their reasons for deciding to pursue a career in internal medicine, a fitting topic for this year’s upcoming Internal

Paul floats bipartisan commission amid Affordable Care Act subsidies battle

Sen. Rand Paul (R-Ky.) called on President Trump to appoint a select group of bipartisan senators to a commission tasked with addressing the expiring health

News and Analysis

Precision BioSciences (DTIL) Provides Updates on Azer-Cel FDA Meeting

Subscribe to newsletter

More Posts

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market

The debate on English tests for immigrant nurses

Celebrating internal medicine through our human connections with patients

Paul floats bipartisan commission amid Affordable Care Act subsidies battle

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company